Biological and conformational studies of [Val4]morphiceptin and [D‐Val4]morphiceptin analogs incorporating cis‐2‐aminocyclopentane carboxylic acid as a peptidomimetic for proline
- 1 May 1991
- journal article
- research article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 37 (5) , 364-381
- https://doi.org/10.1111/j.1399-3011.1991.tb00751.x
Abstract
We report the synthesis, biological activity, and conformational analysis of tetrapeptide analogs related to [Val4] morphiceptin and [d‐Val4]morphiceptin in which the proline at the second position has been replaced with cw‐2‐aminocyclopentane carboxylic acid (cis‐2‐Ac5c). Since the cis‐2‐Ac5c residue contains a normal amide, only the trans form has been observed about the amide bond between the first and second residues. The cis‐2‐Ac5c is a β amino acid with two chiral centers resulting in two possible configurational isomers, namely (1s, 2R) and (1R, 2S) forms. The analogs containing the (1s, 2R)‐Ac5c residue show activity at the μ‐receptor but are inactive at the δ‐receptor, resulting in a high selectivity for the μ‐receptor. The (1R, 2S)‐Ac5c containing analogs are completely inactive at both the μ‐ and δ‐receptors. The conformational analysis indicates that the separation of the aromatic rings of the tyrosine and phenylalanine residues, as expressed by the center‐to‐center distance, is 10.1‐12.7 Å for the preferred conformations of the bioactive analogs containing the (1S, 2R)‐Ac5c residue while a range of 4.8‐7.0 Å is observed for the preferred conformations of the inactive analogs with the (1R, 2S)‐Ac5c residue. A comparison of the findings from the conformational analysis and biological assays establishes the fact that a relatively large separation of the two aromatic side chains is required for the μ‐opioid receptor activity of these molecules. Since the tetrapeptide amides studied in this investigation show similar biological profiles to those of the morphiceptin‐related analogs, we have compared the preferred conformations estimated for the cis‐2‐Ac5c containing analogs with those of morphiceptin. One of the low energy conformations calculated for morphiceptin with the cis form about the tyrosine and proline residues has considerable topological similarity with the bioactive analogs containing the (1S, 2R)‐Ac5c residue, indicating that the cis from about these two residues is required for the biological activity of the morphiceptin‐related analogs containing the proline at the second position.Keywords
This publication has 37 references indexed in Scilit:
- Morphiceptin analogs containing 2‐aminocyclopentane carboxylic acid as a peptidomimetic for prolineInternational Journal of Peptide and Protein Research, 1990
- Opioid peptides from milk proteins.Agricultural and Biological Chemistry, 1986
- MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopyJournal of Magnetic Resonance (1969), 1985
- Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptidesLife Sciences, 1983
- Novel conformational distributions of methylproline peptidesJournal of the American Chemical Society, 1982
- CD and 1 H‐n.m.r. studies on the side‐chain conformation of tyrosine derivatives and tyrosine residues in di‐ and tripeptidesInternational Journal of Peptide and Protein Research, 1982
- Broadband heteronuclear decouplingJournal of Magnetic Resonance (1969), 1982
- Multiple quantum spin-echo spectroscopyJournal of Magnetic Resonance (1969), 1980
- Unsulfated C-terminal 7-peptide of cholecystokinin: A new ligand of the opiate receptorBiochemical and Biophysical Research Communications, 1978
- Nuclear magnetic resonance study of some α-amino acids—II. Rotational isomerismSpectrochimica Acta, 1964